LCM
AMED

Laurion Capital Management’s Amedisys AMED Stock Holding History

Laurion Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,029
Closed -$1.4M – 821
2020
Q2 		$1.4M Buy
+7,029
New +$1.31M 0.02% 356
2019
Q1 		– Sell
-264,725
Closed -$31M – 833
2018
Q4 		$31M Buy
264,725
+262,787
+13,560% +$31M 0.55% 35
2018
Q3 		$242K Buy
+1,938
New +$214K ﹤0.01% 994
2018
Q2 		– Sell
-6,558
Closed -$396K – 1304
2018
Q1 		$396K Sell
6,558
-1,349
-17% -$76.8K ﹤0.01% 1064
2017
Q4 		$417K Buy
+7,907
New +$417K ﹤0.01% 1227

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Laurion Capital Management's AMED Position: Q3 2020 in Review

Laurion Capital Management sold out of Amedisys (AMED) in Q3 2020, closing a stake of 7,029 shares — an estimated $1.4M sold.

Laurion Capital Management first reported a position in AMED in Q4 2017 and held it in 5 quarters. The position peaked at $31M in Q4 2018. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Laurion Capital Management reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • Laurion Capital Management sold 7,029 Amedisys shares in Q3 2020, an estimated $1.4M.
  • Laurion Capital Management first reported a position in Amedisys in Q4 2017 and held it in 5 quarters.
  • Laurion Capital Management's Amedisys position peaked at $31M in Q4 2018.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.